Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0HS8 stock hub

LON/0HS8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HS8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HS8

In the news

Latest news · LON/0HS8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-75.5

P25 n/aP50 n/aP75 n/a

ROIC-51.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HS8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	21
Employees Change	1%
Employees Change Percent	4
Enterprise value	$9M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$20.9M
Price	$3.15
Price currency	USD
Rev Per Employee	6,014.76x
Sic	2836
Symbol	lon/0HS8
Website	https://www.lisata.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-59.02%
EV Earnings	-0.73x
EV/FCF	-0.76x
EV/Sales	72.01x
FCF yield	-56.85%
P/B ratio	1.92x
P/S ratio	165.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$126,310
Gross Profit Growth	-83%
Gross Profit Growth Q	-90%
Net Income	$-12.3M
Pretax Margin	-10,322.35%
Profit Per Employee	$-586,828
ROA	-43.15
Roa5y	-29.37
ROCE	-124.1
ROE	-75.53
Roe5y	-55.3
ROIC	-51.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.59%
Cagr3y	-0.27%
Cagr5y	-32.61%
Revenue Growth	-83x
Revenue Growth Q	-90x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$13.2M
Cash	$11.9M
Current Assets	$13M
Current Liabilities	$2.3M
Equity	$10.8M
Liabilities	$2.3M
Long Term Assets	$198,394
Long Term Liabilities	$82,628
Net Cash	$11.9M
Net Cash By Market Cap	$56.78
Net Cash Growth	-48.71%
Net Debt Equity	$-1.09
Tangible Book Value	$11M
Tangible Book Value Per Share	$1.25
WACC	10.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.76
Net Working Capital	$-983,732
Quick ratio	5.42
Working Capital	$10.9M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.56%
200-day SMA	3.17
3Y total return	-0.82%
50-day SMA	4.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-86.09%
All Time High	72.54
All Time High Change	-95.66%
All Time High Date	2021-01-20
All Time Low	1.88
All Time Low Change	67.55%
All Time Low Date	2026-01-02
ATR	0.17
Beta	1.11
Ch YTD	63.21
High	3.15
High52	5.1
High52 Date	2026-03-31
High52ch	-38.24%
Low	3.07
Low52	1.88
Low52 Date	2026-01-05
Low52ch	67.55%
Ma50ch	-26.74%
Price vs 200-day SMA	-0.54%
RSI	33.07
RSI Monthly	46.32
RSI Weekly	44.16
Sharpe ratio	0.5x
Sortino ratio	1.08
Total Return	-4.3%
Tr YTD	63.21
Tr1m	-37.06%
Tr1w	-5.41%
Tr3m	-31.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-13.5M
Operating margin	-10,711.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,130,250%
Shares Insiders	21.06%
Shares Institutions	7.84%
Shares Qo Q	0.72%
Shares Yo Y	4.3%
Short Ratio	0.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.8M
Average Volume	1,510.6x
Bv Per Share	1.25
CAPEX	$-20,804
Ch1m	-37.06
Ch1w	-5.41
Ch1y	37.56
Ch3m	-31.37
Ch3y	-0.82
Ch5y	-86.09
Ch6m	50.36
Change	-4.55%
Change From Open	2.61
Close	3.3
Days Gap	-6.97
Depreciation Amortization	107,093
Dollar Volume	3.15
Earnings Date	2026-03-30
EBIT	$-13.5M
EBITDA	$-13.4M
EPS	$-1.42
F Score	1
FCF	$-11.9M
FCF EV Yield	-132.13x
Financing CF	445,057
Fiscal Year End	December
Founded	1,980
Income Tax	$-714,766
Investing CF	11,208,898
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2022-09-15
Last Split Type	Reverse
Ma150	3.29
Ma150ch	-4.34%
Ma20	3.59
Ma20ch	-12.35%
Net CF	-187,979
Open	3.07
Position In Range	100
Ppne	13,203.3
Price Date	2026-05-08
Ptbv Ratio	1.89
Relative Volume	0x
Revenue	126,310x
SBC By Revenue	721.18x
Share Based Comp	910,918
Tax By Revenue	-565.88x
Tr6m	50.36%
Volume	1
Z Score	-42.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HS8 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HS8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HS8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.8%

Share of float held by funds and institutions

Insider ownership

+21.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HS8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.1

Neutral momentum band

Price vs 200-day MA

-0.5%

50/200-day relationship not available

Beta (5Y)

1.11

Moves roughly with the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HS8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HS8 stock rating?

lon/0HS8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HS8 analysis?

The full report lives at /stocks/lon/0HS8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HS8?

The latest report frames lon/0HS8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HS8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.